FDA Inspection Readiness Consulting
Mock inspections, readiness assessments and front room support for teams expecting an FDA inspection.
Request a consultation
Get an inspection-readiness review.
Principal-led engagements. 125+ years of combined GMP experience.
The first call is discovery, no confidential details needed. We sign a CDA before any detailed review.
FDA Inspection Readiness Consulting for Regulated Life Science Companies
An FDA inspection can arrive with little warning, and how your facility performs in the first few hours often determines whether you walk away with a clean report or a Form 483. Preparation is not paperwork. It is knowing who does what, having records that agree with each other, and having a team that has answered these questions before.
Amicus prepares pharmaceutical, biotech and 503B teams to face inspections with confidence, and the approach is the same whichever you are. We go beyond identifying gaps in your quality systems and documentation: we work alongside your team to close them, train your people, and build the muscle memory needed to manage a live inspection from the opening meeting to close-out. Whether you are preparing for routine surveillance, a pre-approval inspection, or returning to good standing after a prior 483 or Warning Letter, Amicus brings the hands-on structure that turns inspection anxiety into inspection readiness.
Jamie Duncan, CQAPrincipal, QualityJamie brings nearly a decade of experience in pharmaceutical quality, compliance and operations within highly regulated environments. She holds ASQ Certified Quality Auditor and Certified Manager of Quality/Organizational Excellence certifications, plus a Lean Six Sigma Green Belt.
- Quality system development and optimization
- Internal audits and compliance readiness
- Process improvement and operational excellence
Becca Mitchell, PharmDPrincipal, Quality & RegulatoryWhat usually happens before an inspection
Most teams intend to prepare and then wait for a date. That is understandable. Preparation competes with production, and until there is a letter on the desk it is hard to justify pulling people off the line.
The difficulty is that readiness does not compress well. Documents can be pulled quickly. The parts that decide how an inspection actually goes, whether your people can explain their own systems under questioning and whether your records tell a complete story to someone reading them cold, take longer than the notice period usually allows.
Waiting also removes the cheapest version of every problem. A gap found six months out is a project you schedule. The same gap found during the inspection is an observation, and observations follow you into the next one.
You do not need to commit to a full readiness program to find out where you stand. Tell us what you make and when you were last inspected, and we will tell you what we would look at first.
- Which parts of your quality system would hold up under questioning today
- Whether your records read as complete to an outside reviewer
- Which gaps are quick corrections and which are projects
- How much lead time you would realistically need
Our FDA Inspection Readiness Services
Mock FDA-Style Inspections
We run full mock FDA-style inspections that simulate the pace, pressure and unpredictability of a real visit. Our consultants play the role of the investigator, asking the same probing questions and requesting the same records a field investigator would, so your team practices staying calm, accurate and consistent under scrutiny before it counts.
Documentation and SOP Review
Investigators build their findings from your records. We review batch records, SOPs, validation packages, training files and CAPA logs for completeness, consistency and traceability, correcting the small documentation gaps that so often escalate into observations.
Live Inspection Support
When an inspection is underway, Amicus can be on-site or on standby to support your team in real time, helping you evaluate investigator requests, prepare responses and manage the flow of information without introducing unnecessary risk.
Inspection Readiness Gap Assessments
Before we run a mock inspection we conduct a thorough gap assessment across your facility, quality systems and documentation practices. This benchmarks your current state against FDA expectations and current Good Manufacturing Practice requirements, giving you a clear, prioritized picture of where you stand and what needs attention first.
Front Room and Back Room Preparation
A well-run inspection depends on more than technical compliance. We help you structure and staff your front room and back room teams, define clear roles for document runners, subject matter experts and scribes, and establish the communication protocols that keep an inspection organized from start to finish.
Common Inspection Readiness Challenges We Help Solve
Unclear Roles During Inspections
When staff do not know who owns which response, inspections lose momentum and consistency. We define and rehearse roles in advance so every team member knows exactly what to do when an investigator arrives.
Incomplete or Inconsistent Documentation
Records that contradict each other, or that are missing supporting evidence, are among the fastest routes to a 483 observation. We identify and correct these gaps before an investigator finds them.
Gaps in Quality Systems and Training
An inspection readiness program is only as strong as the quality system behind it. We assess whether your training records, deviation management and CAPA processes can withstand direct questioning, not just a document review.
Risk of FDA 483 Observations
Every recommendation we make is built around reducing your exposure to 483 observations and the downstream cost of remediation, Warning Letters and delayed approvals or shipments.
Why Companies Choose Amicus for FDA Inspection Readiness Consulting
Most consultants stop at telling you what is wrong. Amicus stays to help you fix it. Our team works directly alongside your quality, operations and executive stakeholders to implement corrective actions, train your staff and rehearse the inspection itself, not just hand over a findings report. We tailor every engagement to your facility’s size, product type and regulatory history, so you are not paying for a generic template built for a different company. A principal scopes and leads your engagement and reviews every finding before it reaches you, backed by 125+ years of combined experience across 89 clients.
What Our Clients Say
Our mock FDA audit with Amicus was incredibly helpful. They clearly explained where we had gaps, prioritized the issues, and offered practical ideas for fixing them. It gave our team much more confidence going into future inspections.
Director of Quality503B Outsourcing Facility
Working with Amicus on a mock FDA audit was a great experience. Their team was thorough, professional, and easy to work with, and they provided clear feedback that helped us better understand regulatory expectations.
Pharmacist in Charge503B Outsourcing Facility
Frequently Asked Questions
With an honest baseline rather than a full program. A short readiness review tells you which parts of your quality system would hold up under questioning today and which would not, and that is usually enough to decide what to do next.
Most run two to three days, matching the shape of a real surveillance inspection. Pre-approval readiness engagements are usually longer. We agree scope with you first.
The same people who would face a real inspection: quality leadership, subject matter experts, document runners and scribes. That is the point. Rehearsing with a smaller group teaches your team less than it should.
Yes. We provide live inspection support, on-site or on standby, helping you evaluate investigator requests and manage the flow of information.
Yes. Prior observations tell us where the agency has already looked and what it will check on return. We build the readiness program around that history rather than starting from a blank checklist.
If you have a date, as early as you can. If you do not, readiness is best built as an ongoing capability rather than a project started when the notification arrives.
Related Compliance and Audit Services
FDA 483 & Warning Letter Response
Risk-ranked remediation when observations have already been issued.
Regulatory Compliance Consulting
Strategy, gap assessments and documentation support across FDA requirements.
503B Outsourcing Facility Compliance
GMP and inspection support for registered outsourcing facilities.
Speak With an FDA Inspection Readiness Consultant
If an inspection is on the horizon, or you simply want to know where your facility stands, Amicus can help you get there with confidence. Contact us to schedule a consultation and build a readiness plan tailored to your operation.